Abekma, Breyanzi, CARVYKTI, Qimriyo, Tekartus, Yeskarta
Insonga asoslangan CAR T hujayra terapiyasi: yutuqlar va muammolar
Introduction In the domain of oncology, immunotherapy has emerged as a pioneering methodology, harnessing the body's immune system to combat malignant tumors. There are many immunotherapeutic approaches, but Chimeric Antigen Rece..
Sitokinlarni ajratish sindromini tushunish: sabablari, belgilari va davolash
Introduction Cytokine Release Syndrome (CRS) is an immune system overreaction triggered by therapies like immunotherapy or CAR-T cell treatment. It prompts an influx of cytokines, causing symptoms ranging from fever to potentiall..
ARAVA, CAR T hujayralari, CAR T terapiyasi, CAR-T davolash
CAR T Cell terapiyasining muvaffaqiyatida paramediklarning roli
Patients undergoing outpatient CAR T-cell therapy for cancer must be cared for by a multidisciplinary team that includes nurse coordinators, according to a poster presented at the 49th Annual Oncology Nursing Society Conference. ..
CAR T OITS bilan bog'liq B-hujayrali malign o'smalari uchun hujayra terapiyasi
Introduction CAR T cell therapy, an innovative form of immunotherapy, has demonstrated exceptional efficacy in the treatment of specific tumors by leveraging the potency of a patient's own immune system. Recently, scientists have..
Xitoyda CAR T-hujayra terapiyasi orqali ko'p miyelomni davolashda inqilob
Feb 2024: China's pioneering efforts in creating breakthrough cancer therapeutics have gained traction with the introduction of chimeric antigen receptor (CAR)-engineered T-cell (CAR T) therapy for multiple myeloma, a devastatin..
CAR-T muvaffaqiyatining kaliti bemorni tanlashda yotadi: Siz ideal odammisiz?
Discover the magic of CAR-T treatment! Read our blog on patient selection for CAR T therapy. Are you the ideal candidate for this innovative cancer treatment? Find out and begin your personalized journey to cancer recovery. He..
CAR T hujayralari saraton kasalligini davolashning kelajagini qayta shakllantirmoqda!
The revolutionary CAR T Cell Therapy is changing the scenario of how we deal with cancer, making it more personal and powerful. This latest therapy uses a patient's own immune cells and genetically modifies them to target and des..
CAR - T Uyali terapiya, CAR T-hujayrasi, Kimerik agent retseptorlari, Koreya, Seul, Janubiy Koreya
Koreyadagi kompaniyalar uyda yetishtiriladigan CAR T-Cell terapiyasini rivojlantirishga bir qadam yaqinlashmoqda
2023 yil may: Ximerik antigen retseptorlari (CAR) T-hujayra terapiyasi saratonning individual terapiyasi sohasidagi innovatsion ishlanmadir. Bemorning o'z T-hujayralari ishlab chiqarish jarayonida genetik jihatdan o'zgartiriladi.
Buni Senga Aytganmidim, Yura Park, Yura davri hukmronligi, Sem Nil
"Yura davri parki" aktyori Sem Nilga qon saratoni tashxisi qo'yilgan
2023 yil mart: Sem Neil xotirasining birinchi bobi bu haqda oldindan bilmagan odam uchun katta zarba bo'ladi. Bu juda kulgili boshlanadi: qizi Elenaning otasining ishi haqida so'roq qilinayotgani haqidagi ajoyib ip.
Klinik tadqiqotlar
MESO-CAR T xujayralari relapsli va refrakter epitelial tuxumdon saratoni uchun terapiya
2023 yil mart: Qisqacha ma'lumot: Ushbu klinik sinovning maqsadi anti-MESO antigen retseptorlari CAR T-hujayra terapiyasi qaytib kelgan yoki boshqasiga javob berishni to'xtatgan epitelial tuxumdon saratonini davolash uchun ishlatilishi mumkinligini aniqlashdir.